A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors
Eukaryotic elongation factor 2 kinase (eEF2K) inhibitors may aid in the development of new therapeutic agents to combat cancer. Purified human eEF2K was obtained from an Escherichia coli expression system and a luminescence-based high-throughput screening (HTS) assay was developed using MH-1 peptide...
Saved in:
Main Authors: | Ting Xiao (Author), Rui Liu (Author), Christopher G. Proud (Author), Ming-Wei Wang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanisms underlying the relaxation by A484954, a eukaryotic elongation factor 2 kinase inhibitor, in rat isolated mesenteric artery
by: Tomoko Kodama, et al.
Published: (2018) -
Eukaryotic elongation factor 2 kinase inhibitor, A484954 lowered blood pressure in spontaneously hypertensive rats via inducing vasorelaxation
by: Tomoko Kodama, et al.
Published: (2020) -
Stress-Based High-Throughput Screening Assays to Identify Inhibitors of Cell Envelope Biogenesis
by: Maurice Steenhuis, et al.
Published: (2020) -
Assay development and high-throughput screening for small molecule inhibitors of a Vibrio cholerae stress response pathway
by: Stanbery L, et al.
Published: (2017) -
High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.
by: Roderick G Walker, et al.
Published: (2011)